Cardamyst is supplied as a carton of 2 disposable nasal spray devices, each delivering 2 sprays containing a total of 70mg of etripamil.
UK's health regulator on Monday approved GSK's twice-yearly drug for use as an add-on treatment for asthma in patients aged ...
The 2025 AAO‐HNSF adult sinusitis guideline, an update of the 2015 guideline, offers evidence-based recommendations on rhinosinusitis management.
Zacks Investment Research on MSN
GSK's Nucala for COPD and Depemokimab for asthma get CHMP nod in EU
GSK plc GSK announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ...
Patients with chronic spontaneous urticaria experienced relief in itch and hives by day 3 with povorcitinib, according to ...
Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is ...
Delhi’s polluted winter is especially cruel to those with existing lung conditions. It traumatises them physically and ...
Coming up in the back half of December, the FDA will issue a verdict on Vanda Pharmaceuticals’ gastroparesis drug tradipitant ...
Maryland lawmakers introduce the Affordable Inhalers and Nebulizers Act to reduce the cost of inhalers and expand Medicare ...
Teddy Roosevelt, 26th U.S. President and namesake of the teddy bear, was known for his vigor. Did a gallon of coffee consumed ...
Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.
GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results